Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 31.

Knopfová, L; Biglieri, E; Volodko, N; Masařík, M; Hermanová, M; Glaus Garzón, J F; Dúcka, M; Kučírková, T; Souček, K; Šmarda, J; Beneš, P; Borsig, L (2018). Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding. Oncogene, 37(8):1020-1030.

Ha uselmann, I; Roblek, M; Protsyuk, D; Huck, V; Knopfova, L; Gra ssle, S; Bauer, A T; Schneider, S W; Borsig, L (2016). Monocyte induction of e-selectin-mediated endothelial activation releases VE-Cadherin junctions to promote tumor cell extravasation in the metastasis cascade. Cancer Research, 76(18):5302-5312.

Laubli, H; Varki, A; Borsig, L (2016). Antimetastatic properties of low molecular weight heparin. Journal of Clinical Oncology, 34(21):2560-2561.

Nowicka, A M; Häuselmann, I; Borsig, L; Bolduan, S; Schindler, M; Schraml, P; Heikenwalder, M; Moch, H (2016). A novel pVHL-independent but NEMO-driven pathway in renal cancer promotes HIF stabilization. Oncogene, 35(24):3125-3138.

Schlesinger, Martin; Roblek, Marko; Ortmann, Katrin; Naggi, A; Torri, G; Borsig, L; Bendas, Gerd (2014). The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin. Thrombosis research, 133(5):855-862.

Borsig, L; Wolf, Monika Julia; Roblek, Marko; Lorentzen, A; Heikenwalder, Mathias (2014). Inflammatory chemokines and metastasis – tracing the accessory. Oncogene, 33(25):3217-3224.

Borsig, L; Wolf, M J; Roblek, M; Lorentzen, A; Heikenwalder, M (2014). Inflammatory chemokines and metastasis-tracing the accessory. Oncogene, 33(25):3217-3224.

Hoos, A; Wolf, M J; Bauer, J; Borsig, L; Heikenwalder, M (2012). Endothelial chemokine receptors as facilitators of tumor cell extravasation? OncoTarget, 3(9):919-920.

Sudha, T; Philipps, P; Kanaan, C; Linhardt, R J; Borsig, L; Mousa, S A (2012). Inhibitory effect of non-anticoagulant heparin (S-NACH) on pancreatic cancer cell adhesion and metastasis in human umbilical cord vessel segment and in mouse model. Clinical & Experimental Metastasis, 29(5):431-439.

Puga Yung, G; Borsig, L; Millard, A L; Karpova, M B; Zhou, D; Seebach, J D (2012). Complete absence of the αGal xenoantigen and isoglobotrihexosylceramide in α1,3galactosyltransferase knock-out pigs. Xenotransplantation, 19(3):196-206.

Zelenka, K; Borsig, L; Alberto, R (2011). Metal complex mediated conjugation of peptides to nucleus targeting acridine orange: a modular concept for dual-modality imaging agents. Bioconjugate Chemistry, 22(5):958-967.

Kozlowski, E; Pavão, M S G; Borsig, L (2011). Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin. Journal of Thrombosis and Haemostasis, 9(9):1807-1815.

Rozenberg, I; Sluka, S H M; Mocharla, P; Hallenberg, A; Rotzius, P; Borén, J; Kränkel, N; Landmesser, U; Borsig, L; Lüscher, T F; Eriksson, E E; Tanner, F C (2011). Deletion of L-selectin increases atherosclerosis development in ApoE-/- mice. PLoS ONE, 6(7):e21675.

Borsig, L (2011). Glycans in cancer. In: Pavão, M S G. Glycans in diseases and therapeutics. Berlin, DE: Springer, 63-82.

Bordoli, M R; Stiehl, D P; Borsig, L; Kristiansen, G; Hausladen, S; Schraml, P; Wenger, R H; Camenisch, G (2011). Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis. Oncogene, 30(5):548-560.

Zelenka, K; Borsig, L; Alberto, R (2011). Trifunctional (99m)Tc based radiopharmaceuticals: metal-mediated conjugation of a peptide with a nucleus targeting intercalator. Organic & Biomolecular Chemistry, 9(4):1071-1078.

Läubli, H; Borsig, L (2010). Selectins as mediators of lung metastasis. Cancer Microenviron, 3(1):97-105.

Fuhrer, A; Sprenger, N; Kurakevich, E; Borsig, L; Chassard, C; Hennet, T (2010). Milk sialyllactose influences colitis in mice through selective intestinal bacterial colonization. Journal of Experimental Medicine, 207(13):2843-2854.

Borsig, L (2010). Heparin as an inhibitor of cancer progression. Progress in Molecular Biology and Translational Science, 93:335-349.

Läubli, H; Borsig, L (2010). Selectins promote tumor metastasis. Seminars in Cancer Biology, 20(3):169-177.

Borsig, L (2010). Antimetastatic activities of heparins and modified heparins. Experimental evidence. Thrombosis Research, 125(Suppl2):S66-S71.

Läubli, H; Borsig, L (2009). Heparins attenuate cancer metastasis: are selectins the link? Cancer Investigation, 27(5):474-481.

Laubli, H; Spanaus, K; Borsig, L (2009). Selectin-mediated activation of endothelial cells induces expression of CCL5 and promotes metastasis through recruitment of monocytes. Blood, 114(20):4583-4591.

Borsig, L (2008). The role of platelet activation in tumor metastasis. Expert Review of Anticancer Therapy, 8(8):1247-1255.

Borsig, L. Selectins facilitate metastasis and the role of heparin in cancer. 2008, University of Zurich, Faculty of Medicine.

Elser, M; Borsig, L; Hassa, P O; Erener, S; Messner, S; Valovka, T; Keller, S; Gassmann, M; Hottiger, M O (2008). Poly(ADP-ribose) polymerase 1 promotes tumor cell survival by coactivating hypoxia-inducible factor-1-dependent gene expression. Molecular Cancer Research, 6(2):282-290.

Hostettler, N; Naggi, A; Torri, G; Ishai-Michaeli, R; Casu, B; Vlodavsky, I; Borsig, L (2007). P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins. FASEB Journal, 21(13):3562-3572.

Borsig, L (2007). Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis. Seminars in Thrombosis and Hemostasis, 33(5):540-546.

Borsig, L; Wang, L; Cavalcante, M C M; Cardilo-Reis, L; Ferreira, P L; Mourão, P A S; Esko, J D; Pavão, M S G (2007). Selectin blocking activity of a fucosylated chondroitin sulfate glycosaminoglycan from sea cucumber. Effect on tumor metastasis and neutrophil recruitment. Journal of Biological Chemistry, 282(20):14984-14991.

Garcia, J; Callewaert, N; Borsig, L (2007). P-selectin mediates metastatic progression through binding to sulfatides on tumor cells. Glycobiology, 17(2):185-196.

Stevenson, J L; Varki, A; Borsig, L (2007). Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects. Thrombosis Research, 120(Suppl):S107-S111.

This list was generated on Mon May 28 12:04:51 2018 CEST.